Dallas, Texas (PRWEB) November 12, 2014
One major trend emerging in the acne market is the increased focus on combination therapies, which have led to enhanced safety and efficacy profiles, and have increased patient compliance to the medication.
According to the Global Acne Market 2014-2018 report, one of the main drivers in this market is the significant unmet need. There are a considerable amount of unmet needs in terms of efficacy and safety in the market and this provides immense opportunities for new vendors to enter this market.
The Global Acne market can be divided into 7 segments: Antibiotics, Anti-Inflammatories, Antimicrobials, Combination Medications, Hormonal Agents, Oral Retinoid, and Topical Retinoid. This report provides analysis on types and characteristics of acne. It provides competitive assessment of marketed products. The report also provides rate of incidence and prevalence for US and UK.
The market size is calculated considering the revenue generated from the sales of various drugs and topical creams used in the treatment of acne that are available in the market.
Further, the report states that one of the main challenges that the market faces is the increase in the number of alternative treatments. Because of the availability of alternative treatments, the threat from substitutes is high.
The recognizes the following companies as the key players in the Global Acne Market: Actavis plc, Allergen Inc., Galderma S.A., Stiefel Laboratories Inc. and Valeant Pharmaceuticals International Inc.
Other Prominent Vendors in the market are: Andro Science, Bayer, Cipher Pharmaceuticals, Cosmo Pharmaceuticals, Elorac, Foamix, Helix BioMedix, Hygeia Therapeutics, IMTM, J&J, Mylan Pharmaceuticals, NanoBio, NovaLead Pharma and Roche.
Order a copy of this report at (Prices start at US $2500 for a single user PDF) http://www.sandlerresearch.org/purchase?rname=27078.
List of Exhibits:
Exhibit 1: Market Research Methodology
Exhibit 2: Global Acne Market 2013-2018 (US$ billion)
Exhibit 4: Global Acne Market Segmentation by Category
Exhibit 5: Global Acne Market by Geographical Segmentation 2013
Exhibit 6: Allergen Sales by Portfolio 2012
Exhibit 7: Galderma Sales by Therapeutic Area 2012
Exhibit 8: Global Acne marketBusiness Segmentation 2013
Exhibit 9: Global Acne market Business Segmentation by Revenue 2012 and 2013 (US$ million)
Exhibit 10: Actavis Plc: Sales by Geography (in US$ million)
Exhibit 11: Allergan Inc.: Business Segmentation
Exhibit 12: Allergan Inc.: Revenue by Business Segmentation 2013
Exhibit 13: Allergan Inc.: Revenue Comparison by Business Segmentation 2011-2013 (US$ billion)
Exhibit 14: Allergan Inc.: Revenue by Geographical Segmentation 2013
Exhibit 15: Galderma: Product Segmentation by Revenue 2013
Exhibit 16: Galderma: Geographical Segmentation by Revenue 2013
Exhibit 17: Stiefel Laboratories: Product Segmentation 2013
Exhibit 18: Stiefel Laboratories: Geographical Segmentation by Revenue 2013
Exhibit 19: Valeant Pharmaceuticals International Inc.: Business Segmentation by Revenue 2013
Exhibit 20: Valeant Pharmaceuticals International Inc.: Business Segmentation by Revenue 2012 and 2013 (US$ million)
Exhibit 21: Valeant Pharmaceuticals International Inc.: Sales by Geography 2013
Other New Reports by Infiniti Research on Therapeutics Market:
Global Epilepsy Market 2014-2018: One key trend in this market is the reformulation of marketed drugs. Reformulated drugs, usually, have better tolerability and better dosing schedules than the original drugs. This increases the market acceptance of such drugs, driving their market revenue.
Global Overactive Bladder Therapeutics Market 2014-2018: The key players in the Global Overactive Bladder Therapeutics Market: Actavis plc., Allergan Inc., Astellas Pharma Inc. and Pfizer Inc.
According to the report, the major driving factor of the market is the rise in the geriatric population suffering from various diseases, which are at risk of developing overactive bladder syndrome. This results in an increase in the consumption of drugs for overactive bladder, thereby, boosting growth.
Global Fabry Disease Market 2015-2019: One key trend in the market is an increase in regulatory assistance in emerging nations. Regulatory bodies are steadily working toward developing guidelines and providing assistance to drug manufacturers to promote research in this area.
The key players in the Global Fabry Disease Market: Genzyme Corp. and Shire plc.
Sandlerresearch.org is an online market research store for research reports on multiple industries. These reports provide market analysis, trends and opportunities and forecast about industries that helps to make a right decision for the business.